Table 3.
Complications related to treatment****
| IL SSG | Systemic SSG | |
|---|---|---|
| Occurrence of side effects | 77.26% (n=265/343) | 72.72% (n=24/33) |
| Pain +++ | Pain++Raised liver enzymes +++ | |
| Hyperpigmentation+++ | Headache & Giddiness+++ | |
| Hypertrophic & atrophic scars+++ | Fainting+Myalgias +++ | |
| Milia++ | Hyperpigmentation +++ | |
| Raised liver enzymes - | Hypertrophic & atrophic scars +++ | |
| Postural hypotension+ | ||
| Headache & Giddiness - | ||
| Myalgias - | ||
| Relapse of disease | None at 6 months | None at 6 months |
****Many patients experienced more than one side effect of therapy. +++ Very common; ++ Common; + Less common; Nil. SSG: Sodium stibogluconate